Clin2
NCT06315231Possibly a fitRecruiting

Stroke Recovery Thinking Trial for Recent Stroke Patients

Post-stroke Cognitive Impairment

Treatments studied

Part of Brain & nervous system clinical trials.

This study tests an under-the-tongue tablet (edaravone dexborneol) to help thinking and memory problems that can happen after an ischemic stroke. It may help people who recently had a stroke and now have trouble with attention, memory, or planning.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
226 people
Ages
40 years to 80 years
Study type
Interventional

Who can take part

  • You are between 40 and 80 years old.
  • You had an ischemic stroke (blocked blood vessel) within the last 7 days.
  • You have some trouble with memory, thinking, or attention after your stroke.
  • You did not have serious memory or thinking problems before your stroke.
  • You can read, write, and follow instructions for thinking tests.
  • You do not have severe disability from your stroke (e.g., cannot move one side or speak clearly).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06674460Recruiting· Phase 3
Edaravone Dexborneol tablet for stroke recovery

This trial tests a new sublingual tablet (Edaravone Dexborneol) to help people recover after a small stroke caused by disease of the small blood vessels in the brain. It aims to see if the drug can improve thinking and daily function.

Beijing
NCT06645522Not yet recruiting· Phase 4
Study of edaravone dexborneol for acute stroke

This trial tests a medicine called edaravone dexborneol for people who have had an acute ischemic stroke (a stroke caused by a blood clot). The goal is to see if it is safe and helps improve recovery when given within 48 hours of the stroke starting.

Changchun, Jilin
NCT07260760Not yet recruiting
Testing a neuroprotective drug for recent stroke

This trial studies the safety and effectiveness of edaravone, a neuroprotective drug, in people who have had a mild to moderate stroke in the front part of the brain within the last 48 hours. It aims to see if this drug can help protect the brain from further damage.

NCT07682922Not yet recruiting· Phase 4
Sublingual stroke medicine for transfer to a treatment center

This trial tests if a sublingual (under the tongue) medication called Edaravone Dexborneol can help stroke patients who are being transferred from one hospital to another for a specialized procedure to remove a clot.

Chongqing, Chongqing Municipality
NCT06140888Not yet recruiting
Ginkgo Biloba for Thinking After Stroke

This trial tests whether a ginkgo biloba extract supplement can help improve thinking and memory after a stroke. It is for people who recently had a stroke and have some mild to moderate memory problems, but are not already taking other memory medications.

NCT07604350Not yet recruiting· Phase 3
Edaravone Dexborneol to Prevent Seizures After Stroke

This study tests whether a combination medicine (edaravone dexborneol) can prevent seizures in people who have just had an ischemic stroke (a stroke caused by a blood clot). You would receive this medicine within 48 hours of your stroke if you're at high risk for developing seizures.

Wenzhou, Zhejiang

Hear when a new Post-Stroke Cognitive Impairment (PSCI) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.